ID   PQBP1_RAT               Reviewed;         263 AA.
AC   Q6PCT5;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   24-JUL-2024, entry version 116.
DE   RecName: Full=Polyglutamine-binding protein 1;
DE            Short=PQBP-1;
DE   AltName: Full=Polyglutamine tract-binding protein 1;
GN   Name=Pqbp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Intrinsically disordered protein that acts as a scaffold, and
CC       which is involved in different processes, such as pre-mRNA splicing,
CC       transcription regulation, innate immunity and neuron development.
CC       Interacts with splicing-related factors via the intrinsically
CC       disordered region and regulates alternative splicing of target pre-mRNA
CC       species. May suppress the ability of POU3F2 to transactivate the DRD1
CC       gene in a POU3F2 dependent manner. Can activate transcription directly
CC       or via association with the transcription machinery. May be involved in
CC       ATXN1 mutant-induced cell death. The interaction with ATXN1 mutant
CC       reduces levels of phosphorylated RNA polymerase II large subunit.
CC       Involved in the assembly of cytoplasmic stress granule, possibly by
CC       participating in the transport of neuronal RNA granules. Also acts as
CC       an innate immune sensor of infection by retroviruses, by detecting the
CC       presence of reverse-transcribed DNA in the cytosol. Directly binds
CC       retroviral reverse-transcribed DNA in the cytosol and interacts with
CC       CGAS, leading to activate the cGAS-STING signaling pathway, triggering
CC       type-I interferon production. {ECO:0000250|UniProtKB:O60828}.
CC   -!- SUBUNIT: Interacts with POU3F2/Brn-2, ATXN1, TXNL4A, HTT and AR.
CC       Interaction with ATXN1 correlates positively with the length of the
CC       polyglutamine tract. Interacts with RNA polymerase II large subunit in
CC       a phosphorylation-dependent manner. Forms a ternary complex with ATXN1
CC       mutant and phosphorylated RNA polymerase II. Interacts (via C-terminus)
CC       with TXNL4A and CD2BP2. Interacts (via WW domain) with ATN1 and SF3B1,
CC       and may interact with additional splice factors. Interacts (via WW
CC       domain) with WBP11; Leading to reduce interaction between PQBP1 and
CC       TXNL4A. Interacts with CAPRIN1. Interacts with DDX1. Interacts with
CC       SFPQ. Interacts with KHSRP. {ECO:0000250|UniProtKB:O60828}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O60828}. Nucleus
CC       speckle {ECO:0000250|UniProtKB:Q91VJ5}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:O60828}. Note=Colocalizes with SRSF2 in nuclear
CC       speckles (By similarity). Colocalized with POU3F2. Colocalized with
CC       ATXN1 in nuclear inclusion bodies. Localizes to cytoplasmic stress
CC       granules (By similarity). {ECO:0000250|UniProtKB:O60828,
CC       ECO:0000250|UniProtKB:Q91VJ5}.
CC   -!- DOMAIN: The WW domain may play a role as a transcriptional activator
CC       directly or via association with the transcription machinery. The WW
CC       domain mediates interaction with WBP11, ATN1, SF3B1 and the C-terminal
CC       domain of the RNA polymerase II large subunit.
CC       {ECO:0000250|UniProtKB:O60828}.
CC   -!- DOMAIN: Except for the WW domain, the protein is intrinsically
CC       disordered. {ECO:0000250|UniProtKB:O60828}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC059163; AAH59163.1; -; mRNA.
DR   RefSeq; NP_001013979.1; NM_001013957.1.
DR   AlphaFoldDB; Q6PCT5; -.
DR   SMR; Q6PCT5; -.
DR   STRING; 10116.ENSRNOP00000010536; -.
DR   iPTMnet; Q6PCT5; -.
DR   PhosphoSitePlus; Q6PCT5; -.
DR   PaxDb; 10116-ENSRNOP00000010536; -.
DR   Ensembl; ENSRNOT00055046778; ENSRNOP00055038413; ENSRNOG00055027058.
DR   Ensembl; ENSRNOT00060036695; ENSRNOP00060030206; ENSRNOG00060021122.
DR   Ensembl; ENSRNOT00065018252; ENSRNOP00065013931; ENSRNOG00065011256.
DR   GeneID; 302557; -.
DR   KEGG; rno:302557; -.
DR   UCSC; RGD:1549750; rat.
DR   AGR; RGD:1549750; -.
DR   CTD; 10084; -.
DR   RGD; 1549750; Pqbp1.
DR   eggNOG; KOG3427; Eukaryota.
DR   InParanoid; Q6PCT5; -.
DR   OrthoDB; 5403339at2759; -.
DR   PhylomeDB; Q6PCT5; -.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   PRO; PR:Q6PCT5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005813; C:centrosome; IDA:RGD.
DR   GO; GO:0097546; C:ciliary base; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISO:RGD.
DR   GO; GO:0071598; C:neuronal ribonucleoprotein granule; ISO:RGD.
DR   GO; GO:0016604; C:nuclear body; IBA:GO_Central.
DR   GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB.
DR   GO; GO:0051020; F:GTPase binding; IPI:RGD.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; ISO:RGD.
DR   GO; GO:0002218; P:activation of innate immune response; ISS:UniProtKB.
DR   GO; GO:0000380; P:alternative mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0071360; P:cellular response to exogenous dsRNA; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; ISS:UniProtKB.
DR   GO; GO:1902857; P:positive regulation of non-motile cilium assembly; IMP:RGD.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISS:UniProtKB.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0043484; P:regulation of RNA splicing; ISO:RGD.
DR   Gene3D; 2.20.70.10; -; 1.
DR   Gene3D; 3.40.30.10; Glutaredoxin; 1.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   PANTHER; PTHR28145; 12 KDA HEAT SHOCK PROTEIN; 1.
DR   PANTHER; PTHR28145:SF1; 12 KDA HEAT SHOCK PROTEIN; 1.
DR   SMART; SM00456; WW; 1.
DR   SUPFAM; SSF51045; WW domain; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 1.
PE   2: Evidence at transcript level;
KW   Immunity; Innate immunity; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..263
FT                   /note="Polyglutamine-binding protein 1"
FT                   /id="PRO_0000076091"
FT   DOMAIN          46..80
FT                   /note="WW"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   REPEAT          104..110
FT                   /note="1-1; approximate"
FT   REPEAT          111..117
FT                   /note="1-2"
FT   REPEAT          118..124
FT                   /note="1-3; approximate"
FT   REPEAT          125..131
FT                   /note="1-4; approximate"
FT   REPEAT          132..138
FT                   /note="1-5"
FT   REPEAT          139..140
FT                   /note="2-1"
FT   REPEAT          141..142
FT                   /note="2-2"
FT   REPEAT          143..144
FT                   /note="2-3"
FT   REPEAT          150..151
FT                   /note="3-1"
FT   REPEAT          152..153
FT                   /note="3-2"
FT   REPEAT          154..155
FT                   /note="3-3"
FT   REPEAT          156..157
FT                   /note="3-4"
FT   REPEAT          158..159
FT                   /note="3-5"
FT   REPEAT          160..161
FT                   /note="3-6"
FT   REGION          94..263
FT                   /note="Disordered"
FT                   /evidence="ECO:0000250|UniProtKB:O60828"
FT   REGION          104..138
FT                   /note="5 X 7 AA approximate tandem repeats of D-R-[NS]-H-E-
FT                   K-S"
FT   REGION          139..144
FT                   /note="3 X 2 AA tandem repeats of [DE]-R"
FT   REGION          150..161
FT                   /note="6 X 2 AA tandem repeats of [DE]-R"
FT   REGION          243..253
FT                   /note="Important for interaction with TXNL4A"
FT                   /evidence="ECO:0000250|UniProtKB:O60828"
FT   COMPBIAS        93..202
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         245
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60828"
SQ   SEQUENCE   263 AA;  30529 MW;  0D61E5A815931461 CRC64;
     MPLPVALQTR LAKRGILKHL EPEPEEEIIA EDYDDDPVDY EATRIEGLPP SWYKVFDPSC
     GLPYYWNVET DLVSWLSPHD PNFVVSKSAK KLRNSNADAE DKSERNLEKV DRNHEKSDRS
     HEKPDRSHEK ADRNHEKSDR ERERNYDKVD RERDRDRERE RAFDKADRED GKDRRHHRRE
     ELAPYPKNKK ATSRKDEELD PMDPSSYSDA PRGTWSTGLP KRNEAKTGAD TTAAGPLFQQ
     RPYPSPGAVL RANAEASRSK QQD
//
